Press releases
  • Home
  • > Press releases
  • > Cancer
  • > (French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses

(French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses

Press release | 16 Oct 2012 - 11h08 | By INSERM PRESS OFFICE
Cancer

TO CITE THIS POST :
Press release – Inserm press room (French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses Link : https://presse.inserm.fr/en/french-un-test-automatis-pour-valuer-la-migration-cellulaire-et-l-efficacit-de-nouvelles-mol-cules-anticanc-reuses/4636/

Other contents In the same category :

Cancer Voir tout

communi

Inserm Research Director Jérôme Galon Wins European Inventor Award 2019

Inserm researcher Jérôme Galon has been honored by the European Patent Office (EPO) for his Immunoscore®, a test that predicts relapse risk in patients with certain forms of cancer. An achievement that encapsulates the missions and results of Inserm, a research institute ...
communi

Human “Jumping Genes” Caught in the Act!

Over the course of evolution, the genomes of most living organisms have grown more complex thanks to transposable elements, a.k.a. “jumping genes,” or DNA fragments that can move and copy themselves from one chromosome location to another. Researchers from Inserm, the CNRS, ...
fermer
fermer
RSS Youtube